Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.065 USD | -1.33% | +0.86% | -45.24% |
May. 22 | HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating | MT |
May. 14 | Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.24% | 408M | |
+14.93% | 118B | |
+13.26% | 106B | |
-3.14% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.61% | 15.56B | |
+6.12% | 13.63B | |
+29.02% | 12.27B |
- Stock Market
- Equities
- SLRN Stock
- News Acelyrin, Inc.
- Morgan Stanley Initiates Coverage on Acelyrin With Overweight Rating, $29 Price Target